Asia Pacific and Russia Diagnostic Study for EGFR Testing
NCT ID: NCT01788163
Last Updated: 2017-05-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3500 participants
INTERVENTIONAL
2013-02-27
2016-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
NCT01106781
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
NCT01185314
Europe-Japan Diagnostic Study for EGFR Testing
NCT01785888
An epidemiOlogy Study to deteRmine the Prevalence of EGFR (Epidermal Growth Factor Receptor) muTations in RUSsian Patients With Advanced NSCLC (Non-Small Cell Lung Cancer).
NCT02321046
Acquired Resistant Mechanism of the First-generation EGFR TKIs
NCT02804217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Locally advanced/metastatic NSCLC pats.
Patients with locally advanced (stage IIIA/B) or metastatic NSCLC who have not received any local or systemic chemotherapy, and are not eligible for curative treatment (including surgery and chemoradiotherapy)
EGFR mutation test
EGFR mutation being tested in tissue and blood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EGFR mutation test
EGFR mutation being tested in tissue and blood
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed patients with locally advanced and/or metastatic NSCLC who are systemic treatment Naive (i.e. no chemotherapy or EGFR-TKI) or patients with recurrent disease who have previously received adjuvant chemotherapy (not including EGFR-TKI)
* Provision of diagnostic cancer tissue or cytology sample upon inclusion (surgical specimen, biopsy sample, or cytology sample is acceptable) and Provision of a routine blood (plasma) sample in China, Russia, Taiwan and Korea
* Patients aged 18 years and older
Exclusion Criteria
* Evidence of any other significant clinical disorder or laboratory finding that made it undesirable for the patient to participate in the study
* Pregnancy or breast-feeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rose McCormack, PhD
Role: STUDY_DIRECTOR
AstraZeneca, PHB
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Campbelltown, New South Wales, Australia
Research Site
Coffs Harbour, New South Wales, Australia
Research Site
Concord, New South Wales, Australia
Research Site
Tamworth, New South Wales, Australia
Research Site
Tweed Heads, New South Wales, Australia
Research Site
Wahroonga, New South Wales, Australia
Research Site
Brisbane, Queensland, Australia
Research Site
Woolloongabba, Queensland, Australia
Research Site
Murdoch, Western Australia, Australia
Research Site
Beijing, , China
Research Site
Changsha, , China
Research Site
Changzhou, , China
Research Site
Chengdu, , China
Research Site
Chongqing, , China
Research Site
Foshan, , China
Research Site
Guangzhou, , China
Research Site
Hangzhou, , China
Research Site
Nanjing, , China
Research Site
Shanghai, , China
Research Site
Suzhou, , China
Research Site
Taiyuan, , China
Research Site
Wuhan, , China
Research Site
Zhengzhou, , China
Research Site
Jakarta, , Indonesia
Research Site
Surabaya, , Indonesia
Research Site
Kuala Lumpur, , Malaysia
Research Site
Arkhangelsk, , Russia
Research Site
Barnaul, , Russia
Research Site
Belgorod, , Russia
Research Site
Birobidzhan, , Russia
Research Site
Chelyabinsk, , Russia
Research Site
Chita, , Russia
Research Site
Irkutsk, , Russia
Research Site
Izhevsk, , Russia
Research Site
Kazan', , Russia
Research Site
Kemerovo, , Russia
Research Site
Khabarovsk, , Russia
Research Site
Khanty-Mansiysk, , Russia
Research Site
Krasnodar, , Russia
Research Site
Krasnoyarsk, , Russia
Research Site
Lipetsk, , Russia
Research Site
Moscow, , Russia
Research Site
Novosibirsk, , Russia
Research Site
Obninsk, , Russia
Research Site
Omsk, , Russia
Research Site
Oryol, , Russia
Research Site
Perm, , Russia
Research Site
Pyatigorsk, , Russia
Research Site
Rostov-on-Don, , Russia
Research Site
Ryazan, , Russia
Research Site
Saint Petersburg, , Russia
Research Site
Samara, , Russia
Research Site
Surgut, , Russia
Research Site
Tula, , Russia
Research Site
Ufa, , Russia
Research Site
Veliky Novgorod, , Russia
Research Site
Vladivostok, , Russia
Research Site
Volgograd, , Russia
Research Site
Yakutsk, , Russia
Research Site
Yaroslavl, , Russia
Research Site
Yuzhno-Sakhalinsk, , Russia
Research Site
Singapore, , Singapore
Research Site
Cheongju-si, , South Korea
Research Site
Daegu, , South Korea
Research Site
Seoul, , South Korea
Research Site
Kaohsiung City, , Taiwan
Research Site
Tainan City, , Taiwan
Research Site
Taipei, , Taiwan
Research Site
Chiang Mai, , Thailand
Research Site
Khon Kaen, , Thailand
Research Site
Patumwan Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D7913C00074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.